FDA authorizes the first COVID-19 screening armband device based on machine learning

io" style="margin-top:0px;margin-bottom:10px;padding:0px;max-width:100%;clear:both;min-height:1em;letter-spacing:0.

5px;">The US FDA issued an emergency use authorization (EUA) on March 19 for the first non-diagnostic screening device for COVID-19 based on machine learning, "Tiger Tech COVID Plus Monitor", which can identify and indicate certain symptoms Types of biomarkers, such as blood hypercoagulability (a condition that causes blood to clot more easily than normal).

5px;">The monitor is intended for use by trained personnel to help prevent exposure and spread of the SARS-CoV-2 virus that caused the new crown.

5px;">Jeff Shuren, director of the FDA's Center for Devices and Radiological Health (CDRH), said, “FDA is committed to continuing to support innovative methods to fight the COVID-19 pandemic through new screening tools.

5px;">Similar to many consumer-oriented electronic products and fitness trackers, this device is a wearable armband with an embedded light sensor and a small computer processor.

5px;">